• COVID-19 Vaccine Trial Shows Promise for Elderly

    20 days ago - By Web MD

    If the antibody responses seen in the study translate into protection against the infection, the results could mean the elderly - the population that has been hardest hit by COVID - could receive strong protection from the shot.
    Read more ...

     

  • DPP-4 Inhibitor Tied to Lower Mortality in T2D Patients With COVID-19

    DPP-4 Inhibitor Tied to Lower Mortality in T2D Patients With COVID-19

    20 days ago - By MedPageToday

    Among hospitalized COVID-19 patients with type 2 diabetes, sitagliptin treatment was linked with lower in-hospital mortality, researchers reported.
    In a retrospective study of 338 patients admitted in Northern Italy...
    Read more ...

     

  • COVID-19 Antibodies Lasted At Least 4 Months in Icelandic Study

    COVID-19 Antibodies Lasted At Least 4 Months in Icelandic Study

    20 days ago - By MedPageToday

    Study Authors: Daniel F. Gudbjartsson, Gudmundur L. Norddahl, et al.; Galit Alter, Robert Seder
    Target Audience and Goal Statement: Infectious disease specialists, hematologists, pulmonologists
    The goal of this study was to...
    Read more ...